Relevance of copper transporter 1 and organic cation transporters 1–3 for oxaliplatin uptake and drug resistance in colorectal cancer cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Relevance of copper transporter 1 and organic cation transporters 1–3 for oxaliplatin uptake and drug resistance in colorectal cancer cells
Authors
Keywords
-
Journal
Metallomics
Volume 10, Issue 3, Pages 414-425
Publisher
Royal Society of Chemistry (RSC)
Online
2018-01-30
DOI
10.1039/c7mt00334j
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A fluorescent oxaliplatin derivative for investigation of oxaliplatin resistance using imaging techniques
- (2017) Ganna V. Kalayda et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Assessment of the Relation between the Expression of Oxaliplatin Transporters in Colorectal Cancer and Response to FOLFOX-4 Adjuvant Chemotherapy: A Case Control Study
- (2016) Bertrand Le Roy et al. PLoS One
- Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin
- (2016) Yanqing Liu et al. Science Translational Medicine
- Oxaliplatin in the era of personalized medicine: from mechanistic studies to clinical efficacy
- (2015) Paola Perego et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance
- (2015) E. Martinez-Balibrea et al. MOLECULAR CANCER THERAPEUTICS
- Effect of reactivity on cellular accumulation and cytotoxicity of oxaliplatin analogues
- (2012) Irina Buß et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Drug transporters of platinum-based anticancer agents and their clinical significance
- (2011) Herman Burger et al. DRUG RESISTANCE UPDATES
- Influence of the hOCT2 inhibitor cimetidine on the cellular accumulation and cytotoxicity of oxaliplatin
- (2011) I. Buß et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Enhancing lipophilicity as a strategy to overcome resistance against platinum complexes?
- (2011) Irina Buß et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Muscarinic Receptor Signaling in Colon Cancer
- (2011) Erik C. Von Rosenvinge et al. Cancers
- Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2)
- (2010) H Burger et al. BRITISH JOURNAL OF PHARMACOLOGY
- An ERK-dependent pathway to Noxa expression regulates apoptosis by platinum-based chemotherapeutic drugs
- (2010) C Sheridan et al. ONCOGENE
- Oxaliplatin activity in selected and unselected human ovarian and colorectal cancer cell lines
- (2008) Paul Noordhuis et al. BIOCHEMICAL PHARMACOLOGY
- Significance of Organic Cation Transporter 3 (SLC22A3) Expression for the Cytotoxic Effect of Oxaliplatin in Colorectal Cancer
- (2008) S. Yokoo et al. DRUG METABOLISM AND DISPOSITION
- Structural Requirements for Drug Inhibition of the Liver Specific Human Organic Cation Transport Protein 1
- (2008) Gustav Ahlin et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Role of the Mammalian Copper Transporter 1 in the Cellular Accumulation of Platinum-Based Drugs
- (2008) C. A. Larson et al. MOLECULAR PHARMACOLOGY
- The Role of Cellular Accumulation in Determining Sensitivity to Platinum-Based Chemotherapy
- (2007) Matthew D. Hall et al. Annual Review of Pharmacology and Toxicology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now